Expression of vascular endothelial growth factor in malignant mesothelioma

January 12, 2007 | Comments Off on Expression of vascular endothelial growth factor in malignant mesothelioma

Anticancer Research. 2006 Nov-Dec;26(6C):4833-6. [Link] Aoe K, Hiraki A, Tanaka T, Gemba K, Taguchi K, Murakami T, Sueoka N, Kamei T, Ueoka H, Sugi K, Yoshino T, Kishimoto T. Department…

Differential effects of Ca(2+) on bisphosphonate-induced growth inhibition in breast cancer and mesothelioma cells

January 12, 2007 | Comments Off on Differential effects of Ca(2+) on bisphosphonate-induced growth inhibition in breast cancer and mesothelioma cells

European Journal of Pharmacology. 2007 Mar 15;559(1):21-31. Epub 2006 Dec 9. [Link] Merrell MA, Wakchoure S, Ilvesaro JM, Zinn K, Gehrs B, Lehenkari PP, Harris KW, Selander KS. Department of…

Point of view of Italian regions

January 11, 2007 | Comments Off on Point of view of Italian regions

La Medicina del Lavoro. 2006 May-Jun;97(3):453-7. [Link] Masi M. Regional General Directorate of the Right of the Health, Region of Tuscany, Italy. Abstract The tragic chain of mortal events, that…

Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein

January 11, 2007 | Comments Off on Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein

Molecular and Cellular Biology. 2007 Mar;27(6):2103-19. Epub 2007 Jan 8. [Link] Lee H, Kim D, Dan HC, Wu EL, Gritsko TM, Cao C, Nicosia SV, Golemis EA, Liu W, Coppola…

Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial

January 6, 2007 | Comments Off on Thoracic stop-flow perfusion in the treatment of refractory malignant pleural mesothelioma: a phase I-II evaluation/trial

In Vivo. 2006 Nov-Dec;20(6A):715-8. [Link] Guadagni S, Clementi M, Valenti M, Fiorentini G, Cantore M, Kanavos E, Amicucci G. Department of Surgical Sciences, University of L’Aquila, Italy. stefanoguadagni@interfree.it Abstract Malignant…

Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma

January 3, 2007 | Comments Off on Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma

Journal of Thoracic and Cardiovascular Surgery. 2007 Jan;133(1):111-6. [Link] de Perrot M, Uy K, Anraku M, Tsao MS, Darling G, Waddell TK, Pierre AF, Bezjak A, Keshavjee S, Johnston MR.…

Comparison of the French DRG based information system (PMSI) with the National Mesothelioma Surveillance Program database

December 31, 2006 | Comments Off on Comparison of the French DRG based information system (PMSI) with the National Mesothelioma Surveillance Program database

Revue d’Epidémiologie et de Santé Publique. 2006 Dec;54(6):475-83. [Link] Geoffroy-Perez B, Imbernon E, Gilg Soit Ilg A, Goldberg M. Departement Sante Travail, Institut de Veille Sanitaire, 12, rue du Val-d’Osne,…

Compression of the right main bronchus by a mesothelioma

December 29, 2006 | Comments Off on Compression of the right main bronchus by a mesothelioma

Revue Medicale de Liege. 2006 Nov;61(11):753-5. [Link] Duysinx B, Corhay JL, Nguyen D, Ghaye B, Louis R. Service de Pneumologie, CHU Sart-Tilman, Liege, Belgique. Abstract We report the case of…

Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma

December 29, 2006 | Comments Off on Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma

Modern Pathology (2007) 20, 215–220. [Link] Yasufumi Kato1,2, Koji Tsuta1, Kunihiko Seki1, Akiko Miyagi Maeshima3, Shunichi Watanabe2, Kenji Suzuki2, Hisao Asamura2, Ryosuke Tsuchiya2 and Yoshihiro Matsuno1 Clinical Laboratory, National Cancer Center Hospital, Tokyo, Japan Thoracic Surgery Divisions, National Cancer…

A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma

December 26, 2006 | Comments Off on A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma

European Journal of Cardiothoracic Surgery. 2007 Mar;31(3):529-34. Epub 2006 Dec 26. [Link] Lucchi M, Chella A, Melfi F, Dini P, Ambrogi M, Fino L, Fontanini G, Mussi A. Division of…

Categories